A new filtration process that aims to extend milk’s shelf life may result in a pasteurization-resistant microbacterium passing into milk if equipment isn’t properly cleaned early, Cornell scientists say.
A new study – using lab mice genetically modified with a human gene to shed light on a potential link between arsenic exposure and diabetes – revealed that while the male mice exposed to arsenic in drinking water developed diabetes, the female mice did not.
Deborah Fowell, professor and chair of the Department of Microbiology and Immunology in the College of Veterinary Medicine, has received a five-year, $2.32 million MERIT award from the NIH to study the factors that help guide immune cells.
Fei-Fei Li, co-director of Stanford’s Human-Centered AI Institute, will discuss AI’s role in improving patient safety in health care in the annual Cornell Center for Social Sciences Distinguished Lecture in the Social Sciences, on Oct. 5 in Statler Auditorium.
Researchers from Weill Cornell Medicine have provided the first national estimate of caregivers’ pain and arthritis experiences that can limit their ability to perform necessary tasks while caring for older family members.
Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis drug development.
Prominent physician, author and health services researcher Martin Shapiro will speak at an event on the Ithaca campus. He will describe steps to reform the health care system and lead a discussion that is open to all.
In this episode of the Inclusive Excellence Podcast, Erin Sember-Chase and Toral Patel invite C Lucas, wellness community programming specialist at Cornell, for a conversation about the challenges and complexities that exist in the fitness industry.
An interdisciplinary Cornell research team has developed a new surgical technique that blocks the spread of focal epileptic seizures in the brain by making precise incisions with femtosecond laser pulses.
A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a previously unknown mechanism for insulin regulation in Type 2 diabetes, according to a new study by Weill Cornell Medicine investigators.